Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Vaccination
Primary outcome(s): Safety
Study Design: Single arm Non-randomized
DISEASE(S): Unresectable Colorectal Cancer
PROVIDER: 2616207 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA